"Xalatan" ngeso lehla: yokusetshenziswa

"Xalatan" iso amaconsi aqukethe isithako esebenzayo - latanoprost. Lesi sidakamizwa kungokwalabo iqembu pharmacotherapeutic prostaglandins, thromboxanes, leukotrienes futhi abaphikisi babo.

"Xalatan" ngeso lehla, njengoba e nesakhiwo analog prostaglandin F2alfa, babe antiglaucoma senzo. Nale ekwakhiweni izuzwe ukwanda outflow ka amahlaya aqueous, kanjalo ngincipha ingcindezi intraocular. "Xalatan" iso amaconsi abaziguquli synthesis amahlaya aqueous, futhi musa kuthinte isithiyo igazi aqueous. Mhlawumbe ushintsho oluncane usayizi umfundi. Kakade 3 amahora ngemva instillation "Xalatan" imakwe ukwehla ingcindezi intraocular, lafinyelela umphumela esiphezulu ngemuva kwamahora angu-12. Ukwandisa outflow uveoscleral, azinamphumela ku imfundo yakhe.

Latanoprost kuyinto ether isopropyl (eyandulela asisebenzi) kuthiwa eyenza umuntu acabange eseZwini kahle ngokusebenzisa i-cornea, okuyinto hydrolyzed ukuba ketshezi asebenzayo. It asitholayo umzimba alikho iso, futhi esibindini. metabolites wayo ungenayo i umsebenzi umzimba abizwa excreted ku umchamo.

"Xalatan" eyedrops akhonjiswa ukusetshenziswa kuvulekile-engela ukufiphala isigqugquzeli ingcindezi intraocular. Ukusebenzisa kwabo is contraindicated ebukhoneni hypersensitivity. Ngaphezu kwalokho, ukuqapha kufanele sinikezwe phakathi nokukhulelwa kanye lactation, kanye nezingane. Lesi sidakamizwa ayikhuphuki nokudlondlobala kombungu esizalweni. It ezinqunyiwe ekukhulelweni uma ingozi ukuze umama noma umbungu ingaphansi izinzuzo ngokusetshenziswa kwalo. Ngo kwenkathi lactation kufanele bacabangele yokuthi ifomu iyasebenza, futhi metabolites faka ubisi lwebele.

Kusho "Xalatan" (Umhlahlandlela Kunconywa) wagxilisa 1 isikhathi kusihlwa, 1 ephonsa sac conjunctival. Kumele kuqashelwe ukuthi ukusebenza yayo incipha nge izicelo njalo. Uma kumelwe bangcwabe nezinye amathonsi, kubalulekile ukuba sibethula ngesikhathi esingaba imizuzu okungenani 5.

Naphezu kweqiniso lokuthi ukulungiswa "Xalatan" izilinganiso uthola okuhle, kungase kubangele okulandelayo side effects: hyperemia ka conjunctiva, okungaba okuncane noma okusesilinganisweni edema macular (ngokuvamile kwenzeka in iziguli pseudophakic noma aphakic - ne lens etholakala ekamelweni anterior ), lezivakashi EPITHELIAL ukuguguleka iphuzu nemvelo, umuzwa umzimba angaphandle iso, anda lesikhumba iris e (ngenxa ezishukumisayo melanin zamagama), ukubukeka heterochromia amehlo kungenzeka ngamawala.

Ukusetshenziswa kwalesi izidakamizwa kubangela ushintsho umbala wamehlo ngokufaka efaka sombala nsundu iris. Lo mphumela ivela kaningi kakhulu futhi iningi liphinyiselwe in iziguli elixutshwe nombala (isib grey ansundu noma ensundu-blue) ngenxa ekuqongeleleni melanin. Ngokuvamile lesikhumba zibhebhetheka kusuka sosizo ukuze azungeze iris. Esimeni okukhulu yokwelapha izinguquko umbala kufanele inqanyulwe. Ngemva kweminyaka engu-2 kokusebenzisa ichaza ukushintsha kombala izidakamizwa amehlo enombala ngokulinganayo kwenzeka. Qaphela ukuthi kwaphakama ushintsho iso umbala kungaba engelapheki, ngakho-ke kuyadingeka ukuba axwayise iziguli ngomphumela kungenzeka.

Okuqukethwe ngeso lehla idatha benzalkonium chloride isidingo kokukhipha lens ngaphambi isicelo sabo, ngoba izidakamizwa amuncwa kubo. Faka ngibabone kungaba imizuzu engu-15 ngemva instillation. Ngaphezu kwalokho, kubalulekile ukuba acabangele: ku ngemuva ukusetshenziswa kwalesi izidakamizwa kungadala "umgubuzelo phambi kwamehlo," okudinga ngokuqapha konke okusemandleni ngenkathi ushayela.